NM_001184880.2:c.3439G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2

The NM_001184880.2(PCDH19):​c.3439G>A​(p.Val1147Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 1,202,871 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 39 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1147L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., 10 hem., cov: 23)
Exomes 𝑓: 0.000078 ( 0 hom. 29 hem. )

Consequence

PCDH19
NM_001184880.2 missense

Scores

1
1
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 0.849

Publications

1 publications found
Variant links:
Genes affected
PCDH19 (HGNC:14270): (protocadherin 19) The protein encoded by this gene is a member of the delta-2 protocadherin subclass of the cadherin superfamily. The encoded protein is thought to be a calcium-dependent cell-adhesion protein that is primarily expressed in the brain. Mutations in this gene on human chromosome X are associated with sporadic infantile epileptic encephalopathy and to a female-restricted form of epilepsy (EFMR; also known as PCDH19RE). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
PCDH19 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 9
    Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 107 curated pathogenic missense variants (we use a threshold of 10). The gene has 20 curated benign missense variants. Gene score misZ: 2.5929 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to Dravet syndrome, developmental and epileptic encephalopathy, 9, X-linked complex neurodevelopmental disorder.
BP4
Computational evidence support a benign effect (MetaRNN=0.008261055).
BP6
Variant X-100296285-C-T is Benign according to our data. Variant chrX-100296285-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 206288.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000366 (41/112144) while in subpopulation AFR AF = 0.00126 (39/30890). AF 95% confidence interval is 0.000949. There are 0 homozygotes in GnomAd4. There are 10 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 41 AD,XL,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCDH19NM_001184880.2 linkc.3439G>A p.Val1147Ile missense_variant Exon 6 of 6 ENST00000373034.8 NP_001171809.1 Q8TAB3-1
PCDH19NM_001105243.2 linkc.3298G>A p.Val1100Ile missense_variant Exon 5 of 5 NP_001098713.1 Q8TAB3-2B3KU71
PCDH19NM_020766.3 linkc.3295G>A p.Val1099Ile missense_variant Exon 5 of 5 NP_065817.2 Q8TAB3-3B3KU71

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCDH19ENST00000373034.8 linkc.3439G>A p.Val1147Ile missense_variant Exon 6 of 6 1 NM_001184880.2 ENSP00000362125.4 Q8TAB3-1
PCDH19ENST00000255531.8 linkc.3298G>A p.Val1100Ile missense_variant Exon 5 of 5 1 ENSP00000255531.7 Q8TAB3-2
PCDH19ENST00000420881.6 linkc.3295G>A p.Val1099Ile missense_variant Exon 5 of 5 1 ENSP00000400327.2 Q8TAB3-3
PCDH19ENST00000464981.1 linkn.16G>A non_coding_transcript_exon_variant Exon 1 of 2 3 ENSP00000479805.1 A0A1Y8EN23

Frequencies

GnomAD3 genomes
AF:
0.000366
AC:
41
AN:
112092
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00127
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000282
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000121
AC:
22
AN:
181538
AF XY:
0.0000889
show subpopulations
Gnomad AFR exome
AF:
0.00153
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000148
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000779
AC:
85
AN:
1090727
Hom.:
0
Cov.:
28
AF XY:
0.0000813
AC XY:
29
AN XY:
356645
show subpopulations
African (AFR)
AF:
0.000837
AC:
22
AN:
26272
American (AMR)
AF:
0.00
AC:
0
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19351
East Asian (EAS)
AF:
0.00109
AC:
33
AN:
30179
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
53990
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40521
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4115
European-Non Finnish (NFE)
AF:
0.0000335
AC:
28
AN:
835228
Other (OTH)
AF:
0.0000218
AC:
1
AN:
45869
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000366
AC:
41
AN:
112144
Hom.:
0
Cov.:
23
AF XY:
0.000291
AC XY:
10
AN XY:
34312
show subpopulations
African (AFR)
AF:
0.00126
AC:
39
AN:
30890
American (AMR)
AF:
0.00
AC:
0
AN:
10639
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2648
East Asian (EAS)
AF:
0.000283
AC:
1
AN:
3536
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2657
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6126
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53219
Other (OTH)
AF:
0.00
AC:
0
AN:
1526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000469
Hom.:
2
Bravo
AF:
0.000416
ESP6500AA
AF:
0.00181
AC:
6
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000207
AC:
25

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Jan 20, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 06, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Inborn genetic diseases Benign:1
Sep 06, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Aug 15, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 9 Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.054
DANN
Uncertain
0.98
DEOGEN2
Benign
0.038
.;T;.
FATHMM_MKL
Benign
0.68
D
LIST_S2
Benign
0.78
T;T;T
M_CAP
Benign
0.0099
T
MetaRNN
Benign
0.0083
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.63
.;N;.
PhyloP100
0.85
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.20
N;N;N
REVEL
Benign
0.037
Sift
Benign
0.16
T;T;T
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
0.0020, 0.010
.;B;B
Vest4
0.18
MVP
0.29
MPC
0.41
ClinPred
0.026
T
GERP RS
0.095
Varity_R
0.049
gMVP
0.16
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138771033; hg19: chrX-99551283; COSMIC: COSV55257084; API